Kabra Drugs Limited has clarified that it is exempt from submitting the Annual Secretarial Compliance Report due to its paid-up equity share capital of approximately Rs. 23.7 crore and net worth below Rs. 3.28 crore.

This exemption relieves the company from certain corporate governance provisions, reflecting its smaller scale of operations under the regulator’s criteria.

This update indicates streamlined compliance obligations for the company without impacting its business activities or financial performance.